Prophylaxis of Fungal Infections with Itraconazole during Remission‐Induction Therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1439-0507|32|s1|96-102

ISSN： 0933-7407

Source： MYCOSES (ELECTRONIC), Vol.32, Iss.s1, 1989-11, pp. : 96-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fungal infections during Neutropenia: The Role of Prophylaxis

By  

MYCOSES (ELECTRONIC), Vol. 32, Iss. s1, 1989-11 ,pp. : 88-95

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum posaconazole levels during acute myeloid leukaemia induction therapy: correlations with breakthrough invasive fungal infections

By  

MYCOSES (ELECTRONIC), Vol. 58, Iss. 6, 2015-06 ,pp. : 362-367

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high‐risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real‐world comparison

By  

MYCOSES (ELECTRONIC), Vol. 61, Iss. 3, 2018-03 ,pp. : 206-212

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetic–pharmacodynamic study of itraconazole in patients with fungal infections in intensive care units

By Hagihara Mao   Kasai Hidefumi   Umemura Takumi   Kato Takahiro   Hasegawa Takaaki   Mikamo Hiroshige  

Journal of Infection and Chemotherapy, Vol. 17, Iss. 2, 2011-04 ,pp. : 224-230

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Itraconazole in Preventing and Treating Systemic Fungal Infections in Immunocompromised Patients

By  

Acta Haematologica, Vol. 111, Iss. 3, 2004-03 ,pp. : 175-180

Karger

Access to resources Recommend Favorite